REVERSAL OF HAEMOCHROMATOTIC CARDIOMYOPATHY IN BETA-THALASSEMIA BY CHELATION-THERAPY

被引：0

作者：

POLITI, A ^{[1
]}

STICCA, M ^{[1
]}

GALLI, M ^{[1
]}

机构：

[1] ST ANNA HOSP,DEPT PAEDIAT,I-22100 COMO,ITALY

来源：

BRITISH HEART JOURNAL | 1995年 / 73卷 / 05期

关键词：

HAEMOCHROMATOTIC CARDIOMYOPATHY; BETA THALASSEMIA; CHELATION THERAPY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Haemochromatotic cardiomyopathy is the main cause of morbidity and mortality in patients with beta thalassaemia major. Once congestive heart failure develops most patients die in a few months. Congestive heart failure was reversed and echocardiographic findings were restored to normal in a 24 year old woman with beta thalassaemia who resumed treatment with chelation therapy (desferrioxamine).

引用

页码：486 / 487

页数：2

共 6 条

[1]

ALDOURI MA, 1990, ACTA HAEMATOL-BASEL, V84, P113

[2] PROLONGED SURVIVAL IN PATIENTS WITH BETA-THALASSEMIA MAJOR TREATED WITH DEFEROXAMINE [J].